Navigation Links
Indiana U. professor to examine how women respond to information about the HPV vaccine


INDIANAPOLIS, Ind. -- Dena S. Cox, a professor of marketing and faculty fellow at the Kelley School of Business Indianapolis, has received a $99,600, two-year research grant from Merck to study factors influencing young women's adoption of the human papillomavirus (HPV) vaccine.

Cox's research investigates how people make medical-treatment decisions, examining the effects of health communication on consumers' adoption of preventive behaviors. In the study, she is exploring the most effective ways to present information to women ages 18 to 26 about the benefits and risks of the HPV vaccine.

HPV is the most common sexually transmitted infection, according to the Centers for Disease Control and Prevention. Most people with the virus do not develop symptoms or health problems. However, some HPV types can cause genital warts and cervical cancer.

In the study, Cox will employ a nationwide, Internet survey panel to recruit young women who have not received the HPV vaccine. She will present them with information on vaccination benefits and risks, in a variety of presentation formats.

The study will then assess the women's understanding of this information, their attitudes and intentions toward vaccination, and, six months later, their vaccination behavior. The study seeks to determine which presentation formats are most helpful to young women in making informed decisions about HPV vaccination.

"Medical information often is complex," said Cox. "How you frame the information and its personal impact will influence the way people think and behave. We believe that the more an individual processes and understands the information, the more likely she is to participate in a healthy action, like HPV vaccination."

Each year, about 12,000 women in the U.S. get cervical cancer, and about 4,000 die from the disease. Cervical cancer largely is preventable through Pap screening tests and the HPV vaccination. However, healthy women in their late teens and early 20s may not consider themselves at risk. Cox's study will help health care professionals better communicate with young women about the risks of cervical cancer and the importance of preventive measures, including HPV vaccination.

This is Cox's second research grant from Merck. Her co-investigators on this study include Anthony Cox, Chancellor's Faculty Fellow and professor of marketing at Kelley, and Gregory Zimet, professor of pediatrics and co-leader of the Cancer Control program in the IU School of Medicine. The Kelley School Indianapolis is based at the Indiana University-Purdue University Indianapolis campus.


Contact: Brenda Bishop
Indiana University

Related medicine news :

1. New book by Indiana University physicians slays health myths we all thought were true
2. Indiana University neuroscientists map a new target to wipe pain away
3. Indiana U. study points to health disparities in physical fitness
4. A safer, more effective morphine may be possible with Indiana University discovery
5. Grant launches cervical cancer-free Indiana initiative
6. APHA 2010: Study finds funding for substance abuse in Indiana lacking
7. Indianapolis to host international conference on frontotemporal dementias
8. NRPA Launches National Hunger Relief Initiative at Indianapolis' Douglass Park
9. Indiana Home and Hospice Care Foundation Selects Pearson to Bolster Workforce Training Initiatives
10. National Insurance Company Looks to Indianapolis-based TriDigital Solutions for Affordable CD Replication and Mailing Project
11. Indiana Boudoir Photographer Begins Shooting Breast Cancer Charity Calendar
Post Your Comments:
Related Image:
Indiana U. professor to examine how women respond to information about the HPV vaccine
(Date:11/30/2015)... ... November 30, 2015 , ... The American Society for Clinical Pathology ... World AIDS Day 2015. On Nov. 30, ASCP shared its “Give a minute. Get ... AIDS Day and the importance of getting tested for HIV. , ASCP has asked ...
(Date:11/30/2015)... (PRWEB) , ... November 30, 2015 , ... While powdered ... results in wasted time. Fortunately, an inventor from Chesterfield, Va., has found an easy ... to keep the scoop used to measure powdered contents in a canister or other ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... to its industry-leading suite of automated breast density assessment and enterprise analytics ... meeting, November 29-December 4, 2015 (South Hall booth #2377). Volpara’s quantitative breast ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... for “Value-Based Payer-Provider Partnerships: Three Case Studies,” an upcoming Dec. 8 virtual ... Essentia Health and UCare, MissionPoint Health Partners, and Intel Corp. Leaders from ...
(Date:11/30/2015)... ... November 30, 2015 , ... Insightra Medical, Inc. ... Surgical Mesh technology for soft tissue repair in the US via Insightra’s national ... resorbable surgical mesh intended to support and reinforce soft tissue for 6-9 months ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... Belgium , Nov. 30, 2015   VolitionRx ... on developing blood-based diagnostic tests for a broad range of ... present at the LD Micro Conference, which will be held ... Attending from VolitionRx will be David Kratochvil ... , Vice President of Investor Relations. ® ...
(Date:11/30/2015)... Israel , Nov. 30, 2015 /PRNewswire/ ... on acquiring and developing innovative therapies for ear, nose, ... Keith A. Katkin as chairman of the ... , chief executive officer for OticPharma, Ltd.  "Keith brings ... chairman, he will be able to share this experience ...
(Date:11/29/2015)... 29, 2015   Royal Philips  (NYSE: PHG, AEX: ... at the 2015 Radiological Society of North America Annual ... Place in Chicago . Visitors to ... company,s broad portfolio of integrated Diagnostic Imaging, Clinical Informatics, ... clinical performance, improve workflow and create a superior patient ...
Breaking Medicine Technology: